KB105

· Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KB105, covering 2021-09-13 to 2023-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) [Phase 2]